A randomized, double-blind, dose-ranging, placebo-controlled study to evaluate the efficacy and safety of PLN-74809 (bexotegrast) for the treatment of idiopathic pulmonary fibrosis (BEACON-IPF)

Project: Research

Project Details

StatusActive
Effective start/end date29/01/24 → 29/01/26

Keywords

  • clinical trial
  • pulmonary fibrosis
  • bexotegrast